Title : Liver Fat, Adipose Tissue, and Body Composition Changes After Switching from a Protease Inhibitor or Efavirenz to Raltegravir.

Pub. Date : 2021 Sep

PMID : 34524919






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Liver Fat, Adipose Tissue, and Body Composition Changes After Switching from a Protease Inhibitor or Efavirenz to Raltegravir. Raltegravir Potassium FAT atypical cadherin 1 Homo sapiens
2 Integrase inhibitors appear to increase body weight, but paradoxically some data indicate that raltegravir (RAL) may decrease liver fat. Raltegravir Potassium FAT atypical cadherin 1 Homo sapiens